Stockreport

Arbutus Presents HBV Data at 2017 AASLD Liver Meeting

Arbutus Biopharma Corporation  (ABUS) 
Last arbutus biopharma corporation earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.arbutusbio.com/node/5806
PDF Phase 2 ARB-1467 Combination Study Starting in 4Q17Expected IND-filings in 2018 for Two New Oral Compounds VANCOUVER, British Columbia and WARMINSTER, Pa., Oct. 24, 20 [Read more]